Emily’s Entourage Celebrates Landmark Achievement: First Patient Dosed with Novel Gene Therapy Developed Through EE’s Visionary Model
Philadelphia, Pennsylvania—November 18, 2024—Emily’s Entourage (EE), an innovative 501(c)3 accelerating research for new treatments and a cure for the final 10% of people with cystic fibrosis (CF), proudly announces a pivotal milestone in its mission to speed breakthroughs for those with CF who do not benefit from currently available mutation-targeted therapies: Spirovant Sciences, a clinical-stage gene therapy company that EE helped launch,... Read More
